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doi:10.1016/j.ejvs.2009.01.016Abstract Objective: To retrospectively analyse injection drug users (IDUs) with complica-
tions after intra- or extra-vasal administration of dissolved tablets.
Design: A retrospective study.
Methods: The hospital discharge registers were used to identify the patients admitted in
different clinics in Helsinki University Central Hospital during 2000e2005. The patient demo-
graphics and social background were clarified. The type of the crushed drugs, the injection
route and the timing of administration were registered. Medical interventions, examinations
and surgical procedures were recorded.
Results: Between January 2000 and December 2005, 24 patients had been treated on 30 occa-
sions for manifestations caused by injecting crushed tablets. The main types of manifestations
were acute limb ischaemia (16 patients) and infection (eight patients), and eight cases led to
distal or proximal amputations. Men (19 of 24) were affected more frequently than were
women (5 of 24). Their ages ranged between 20 and 39 years (mean: 26 years). All the patients
had a previous history of intravenous drug abuse, and they lived in Greater Helsinki region. The
incidence of seropositivity for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immu-
nodeficiency virus (HIV) was 33% (nZ 8), 88% (nZ 21) and 4% (nZ 1), respectively. The time
between injection and presentation to the Emergency Department varied between 3 h and
10 days (mean: 62 h). Buprenorphine was the most commonly used drug in 10 of the 24
patients, and benzodiazepine derivatives were also used in 11 of the 24 patients.504279663; fax: þ358 947187570.
us.fi (T.A. Partanen).
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Drug Abusers’ Complications 705Conclusions: Intra- or extra-vasal administration of dissolved tablets leads to serious conse-
quences, including limb amputations. Vascular and soft-tissue imaging may be helpful in the
diagnosis. Prompt drainage of any abscess and fasciotomies for compartment syndrome treat-
ment are essential. Controversy exists over the best medical therapy.
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Board (INCB) that prescription drugs will replace illicit
drugs in the developed countries before 2010.1 If the esti-
mated trend is kept, both vascular and infectious problems
with crushed tablets will increase in the future. Adminis-
tration of the prescription drugs is usually oral, but when
higher bioavailability is pursued, abusers crush or pulverise
the tablets and dissolve them in water. The spectrum of
vascular complications that the drug abuse may result in is
wide: cutaneous manifestations, pseudo-aneurysms,
infected deep vein thrombosis and tissue ischaemia (skin
necrosis, muscle necrosis and nerve injury).2e4
Accidental, unintentional, intra-arterial (IA) injections
do occur, although infrequently, in normal clinical work.5
Iatrogenic IA injections of barbiturates and benzodiaze-
pines have been shown to lead to permanent injuries in
spite of being dilute solutions and their administration in
monitored environment.6 The complex IA process that is
possibly caused by a diluted crushed tablet is accelerated
by contaminants such as microbes, powder-filling
substances and drug crystals.7
Even though the injection drug users (IDUs) are young
and have no underlying vascular disease (atherosclerosis or
diabetes), previous intravenous (IV) drug abuse might have
affected peripheral veins that would have become scle-
rosed.4 In addition, the previous damage to collateral
arteries due to infections and intimal trauma may increase
the risk of tissue necrosis after IA crushed-tablet injections.
The psychological problems of IDUs are associated with
poor cooperation and life control that complicate all
attempts to treat them. In addition to drug addiction, these
patients are likely to have other mental health problems
such as attention deficit hyperactivity disorder (ADHD) and
asocial behaviour.8
The purpose of this study was to report the disease
pattern and consequences in IDUs who have injected
diluted crushed tablets in the extremities. According to our
knowledge, this is the first study to report this kind of
a patient group.
Material and Methods
A retrospective chart review of the hospital disease register
found 24 patients who had injected crushed tablets. The
number of patients treated by plastic, vascular and/or hand
surgeons in Helsinki University Central Hospital during
2000e2005 were 15, 12 and 6, respectively. Their medical
records were collected and analysed. Demographics and
social background were clarified. The type of crushed
drugs, the route and the timing of administration were
examined. Medical interventions, examinations and
surgical procedures were recorded.
The study was approved by the Ethical Committee of
Helsinki University Central Hospital.Results
All 24 patients, with ages ranging 20e39 years (mean: 26
years) and in a 4:1 male-to-female ratio, come from
Greater Helsinki area (population around 1.2 million). One
patient was a Russian immigrant and the rest of them were
native Finns. All patients had previous history of intrave-
nous drug abuse. Eight of them had an earlier sentence of
imprisonment.
Somatically, the patients were quite healthy even
though they had a significant amount of viral infections
typical for drug abusers. The incidence of hepatitis B virus
(HBV) seropositivity was 33% (eight patients), and 88% of
the patients (21 patients) tested positive for hepatitis C
virus (HCV). One female was a human immunodeficiency
virus (HIV) carrier. Previously, 24% of them had recorded
infection in their medical files due to drug abuse. One male
was on medication for cardiac insufficiency and arrhythmia.
One patient was queuing for the maintenance treatment
for opiate addiction. Twelve out of 24 patients were on
maintenance treatment: six of them on methadone and the
other six on buprenorphine. Mental health diagnoses were
reported in eight patients.
The crushed tablets were dissolved in water, usually tap
water which was sometimes boiled. There was only one
record on using filters before administration of the drug.
Majority of the patients (nZ 19) injected crushed tablets in
the non-dominant upper extremity. Five patients were
treated due to a second similar incidence on an average of
1 year 5 months (range: 1 monthe3 years 2 months) after
the first incidence.
Buprenorphine was the most commonly used drug in 10 of
the 24 patients, and benzodiazepine derivatives were also
used in 11 of the 24 patients. Two IDUs had concomitant
injection of other psychotropics in addition to buprenor-
phine. A combination of buprenorphine, dextroproxyphene
and heroin was observed in one case. There were 16 arterial
injections (Table 2), 2 venous injections and 10 soft-tissue
injections (Table 1). The injection time was reported in 67%
of the cases. The time between injection and presentation
to the Emergency Department varied between 3 h and 10
days (mean: 62 h).
Patients who had injected crushed tablets were hospi-
talised mainly due to acute limb ischaemia (nZ 16) and
secondly due to infection (nZ 8). Many times, infection co-
occurred with ischaemia. Septic symptoms, high tempera-
ture and reduced general condition led to hospitalisation in
seven patients. However, only two out of eight blood
cultures were positive (Streptococcus constellatus, Bacillus
Cereus). Staphylococcus epidermidis (nZ 5), Staphylo-
coccus aureus (nZ 3), Streptococcus pyogenes (nZ 3) and
Streptococcus anginosus (nZ 3) were the most common
pathogens cultured from the wound bed. Femoral osteo-
myelitis was the most serious infectious complication.
Table 1 Crushed-tablet drug and injection sites in injec-
tion drug users (nZ 29 incidences, 24 patients)
Artery Vein Extra-vasal Total
Benzodiazepine derivative
Alprazolam 3 3
Diazepam 2 2
Midazolam 6 1 7
Temazepam 3 2 2 7
Other euphorising analgesics
Dextropropoxyphene 1 1
Buprenorphine 4 6 10
Total 18 2 10 30
706 T.A. Partanen et al.Patients stayed on ward on an average for 14 days (range:
0e51 days) and underwent a range of zero to six surgical
procedures. Primarily, the affected areas were debrided
and fasciotomies performed if necessary. Later, the wounds
were covered with skin grafts or closed directly.
Embolectomy was performed in three cases in which the
flow obstruction was shown by ultrasound or angiography.
In spite of the invasive procedures, these cases ended up in
amputations and/or permanent disabilities such as func-
tional hand deficits (nZ 3), muscle weakness, rigidity
(nZ 1) and numbness of the finger tips (nZ 1) or hyper-
aesthesia (nZ 1). In one case, injection of crushed alpra-
zolam to femoral artery caused the loss of the peroneal
function and muscular necrosis in the anterior compart-
ment (Fig. 1AeC). The IA injections led to severe problems:
finger amputations (nZ 5), toe amputations (nZ 1), cubi-
tal exarticulation (nZ 1) and upper arm amputation
(nZ 1).
All patients with IA injections received either dalteparin
2500d10 000 IU 2 per day or enoxaparin 20e60 mg 2.
Five patients received acetylsalicylate alone or in combi-
nation with low-molecular weight heparin (LMWH). Iloprost
infusion was administered in four patients who presented
within 24 h after IA injection and showed typical clinical
manifestations of limb ischaemia. The fourth iloprost
patient had injected alprazolam into his femoral artery,
and despite the treatment he lost his anterior crural
compartment. One patient received clopidogrel bisulphate
75 mg for 30 days.
Three patients with brachial artery injection recovered
from the incident. One of them repeated the midazolam
injection 3 years later but received only painkillers and was
treated by a general practitioner. Later, her index finger
was amputated, and the flexion and sensation of the
remaining fingers remained deficient.
Ropivacaine infusion was initiated in 10 patients during
the first surgical intervention, and it was continued as
postoperative pain treatment 0e12 days after the
procedure.
Discussion
The pathophysiological mechanisms that occur after IA
injection of crushed tablets are controversial.3 Most of the
theories are based on animal model observations. The
obstruction of the vessel lumen is thought to result fromnorepinephrine-mediated vasoconstriction, crystals, endo-
thelial inflammatory reaction, direct cytotoxicity, venous
constriction, lipid solubility and/or high osmolality of the
injected agent. In humans, case reports about one or two
patients are numerous, but in the light of the prospective
studies no treatment is proven superior.
Buprenorphine was the most commonly used drug among
treatment-seeking IDUs in 2005 in Finland.9 In addition, this
painkiller has replaced heroin as the primary abused drug
by 29% of IDUs. As a prescription drug, buprenorphine is
available for sublingual use and is easily sold on the streets.
The popularity of buprenorphine was observed in our study.
Benzodiazepines are drugs that have been previously
reported to cause severe complications after IA injection.10
The high incidence of ischaemia and necrosis is thought to
be caused by high-lipid solubility. In our study, 16 injections
of the benzodiazepines were shown to cause tissue
ischaemia that led to amputations in five cases and to
functional impairment in three cases.
The median time delay between the injection and
patients’ arrival to the hospital was found to be over 2.6
days. By that time, the symptoms of compartment
syndrome were apparent in eight patients, resulting in
a high number of fasciotomies (nZ 9). The delay narrows
the possibilities for therapeutic interventions. On the other
hand, if the IDUs present at the emergency department
several hours after the incidence, surgical embolectomy
seldom saves the limb. The vessels have a high tendency to
become re-thrombosed. A typical finding in an angiogram in
our material was a distally located obstruction that was
beyond surgery or endovascular treatment.
The use of intravenous unfractioned heparin is recom-
mended to prevent thrombosis and to avoid occlusion of the
collaterals.6 Heparin infusion should be continued as long
as visible signs of ischaemia (skin mottling, cramping and
limb swelling) persist and the symptoms have significantly
alleviated: that is, 5e10 days after injection.11
A combination of nervous plexus blockade and intrave-
nous heparin also has been shown to be effective.12,13 In
addition, the pain relief used in nerve blockade, ropiva-
caine, acts as a vasodilator. Our patients were not given
unfractioned heparin, but they were administered LMWH.
Many authors recommend anticoagulation therapy for
3 months.6 After LMWH therapy, our patients did not
receive any oral anticoagulation.
The data on IA vasodilators or prostacyclin infusion are
scant, and the arterial vasospasm associated with IA
injection is transient in nature.14 However, prostacyclin
analogue, iloprost has been used with encouraging results
both as well in small earlier published series and in our
patients with upper limb ischaemia.15 A double-blinded
trial with 133 patients showed that a critical leg ischaemia
caused by thromboangitis obliterans (Bu¨rger’s disease) was
relieved by iloprost infusion.16 There is no evidence-based
studies on selective IA injection of thrombolytic therapy
with patients who have used crushed-tablets IA, and thus
we did not try it.
Wound-bed cultures showed low-virulent microbes of
skin and oral origin that can be explained by the patients’
young age and lack of underlying diseases.17 Serious, deep
infections may hide behind the sub-acute clinical course
and focal infection signs should be imaged by ultrasound or
Table 2 Crushed-tablet drug users with ischaemia symptoms and their other incidences by using the same kind of injection ‘material’
Patient/case/
time
Sex Drug Site Delay Conservative
treatment
EVS/finding Surgical intervention Outcome
1 (5/2000) M alprazolam right
forearm/IA
48 h dalteparin
2500 IU 1
DD/negative Day 2 fasciotomy, transversal lig
discion in the wrist
Elbow amputation
Day 9 Right hand MCPI-V
amputations
Right forearm debridement.
Day 17 Right cubital joint
exarticulation.
2/I (1/2002) F midazolam right arm/IA 4 h iloprost DD/negative None Stiffness
dalteparin
5000 IU 2
II (3/2005) midazolam right arm/IA 48 h dalteparin
5000 IU 2
Not done Day 1 Brachial artery embolectomy
attempt.
Brachial artery
embolectomy
attempt.
Forearm and hand fasciotomies.
Day 8 II finger amputation, wound
debridement, wound closure, skin
graft
3 (9/2003) M temazepam right hand
dorsum/IV
dalteparin
2500 IU 2
Not done Day 2 Fasciotomy, transversal lig
discision in the wrist.
Descended
strength
Day 7 Hand and forearm
debridement.
Skin graft.
4 (2/2005) M midazolam right cubital
fossa/IA
4 h dalteparin
5000 IU 2
DD/positive Day 2 Radial artery
thromboembolectomy.
Tendency to wrist
flexion
Debridement, skin graft.
5 I (1/2000) M buprenorphine left arm/IN? 48 h None Not done No Claw hand
II (10/2002) midazolam left
forearm/IA
12 h iloprost DD/negative Day 4 Hand and forearm
fasciotomies.
Scarred IVeV
finger tips
dalteparin
2000 IU 2
Angiogram/
negative
Clumsy hand
acetylsalicylate
100 mg
6 I (7/2003) M buprenorphine left cubita/
IA
dalteparin
2500 IU 2
DD/negative No Auto-amputated II
finger tip
acetylsalicylate
100 mg
II (11/2003) buprenorphine neck/EV 14 days None Not done Day 1 Incision. Normal
III (6/2005) buprenorphine right leg and
thigh/EV
Not known None Not done Day Debridement, fasciotomies,
fasciectomies.
Normal
(continued on next page)
D
ru
g
A
b
u
se
rs’
C
o
m
p
lica
tio
n
s
707
Table 2 (continued)
Patient/case/
time Sex Drug Site Delay
Conservative
treatment EVS/finding Surgical intervention Outcome
7 I(3/2005) M midazolam right
cubita/IA
12 h dalteparin
5000 IU 1 single
doses
DD/negative No Normal
II (12/2005) alprazolam right
cubita/IA
2 h enoxaparin
40 mg 1
DD/positive Day 60 Amputation of I-V fingers’
distal phalanges.
Right hand fingers
distal phalanx
amputated
Day 120 II finger debridement.
8 I (1/2004) M temazepam left thenar/
IA
10 days None DD/positive No Thenar/pollicis
muscles’ weakness
II (8/2004) temazepam left small
finger’s
volar, radial
site/IA
None DD/negative Day 38 III-V fingers’ partial
amputation and debridement.
Middle finger tip
deformity
buprenorphine Day 67 Debridement and
reamputation.
Ring and small
fingers amputated
1.5 cm distal to
PIP joint
Hyperaesthesia in
middle finger’s
tip
Pressing force
decreased
40/12 kg
Cold sensitivity
9 I (7/2002) M buprenorphin left cubita/
IA
12 h enoxaparin
80 mg 1
DD/negative No Normal
amphetamin
10 (9/2003) M buprenorphin left hand/IA 2e3 days dalteparin
7500 IU 2
DD/positive Day 14 IV finger partial amputation. Ring finger middle
phalax level
amputatedclopidogrel
bisulphate 75 mg
30 days
Angiogram/
negative
11 (1/2005) F diazepam left pollicis
base/IA
2 days dalteparin
5000 IU 2
DD/positive Day 2 Discision, fasciotomy. Pollicis distal
phalax half
amputated
10 months later partial thumb
amputation.
12 (9/2005) M midazolam right
forearm/IA
24 h dalteparin
5000 IU 2
DD/positive Day 1 Forearm fasciotomy,
transversal ligament discision.
Forearm half
amputated
Day 15 Forearm amputation.
Day 20 Skin graft.
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13 (2/2005) M temazepam left wrist/IA enoxaparin
60 mg 2
DD/positive Day 1 Fasciotomies for the dorsal
side of hand and thenar region,
transversal ligament discision in the
hand.
Pollicis half
amputated
Day 20 I, III-V fingers’ partial
amputation, II finger and IV finger’s
wound debridement.
DIP level middle
and ring finger
amputation
Day 40 II finger debridement.
14 (4/2005) M alprazolam right groin/IA 24 h dalteparin
10 000 2
acetylsalicylate
100 mg
DD/negative Day 1 Femoral artery embolectomy
attempt and fasciotomy.
Half amputated
toe, II toe total
amputation,
partially
amputated III-V
toes
iloprost Day 16 femoral fasciotomy wound
closure
Peroneal
insufficiency stays!
re-revisio cruris l. dx.
Day 27 Debridement and skin graft.
Day 89 Debridement, skin graft.
II toe amputation, I, III, IV toes’
partial amputation.
After 9 months II MT region’s
fistulectomy.
15 (10/2003) M diazepam left cubital
fossa/IA
9 h dalteparin
5000 IU 2
DD/positive None Neuropathy
acetylsalicylate
100 mg
Angiogram/
positive
16 (5/2005) F temazepam right cubital
fossa/IV
24 h None Not done Day 1 Forearm fasciotomy. Normal
Day 8 Wound closure, skin graft.
EVS, examinations by vascular surgeons; DD, duplex ultrasound; IA, intra-arterial; IV, intra-venous; EV, extra-vasal; IN, intra nerval.
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Figure 1 (A) A typical clinical manifestation of micro-emboli found in the skin as purpuric lesions after injection of crushed
alprazolam in the femoral artery. (B) Cutaneous and muscle necrosis corresponding to the territory of the tibial anterior artery 14
days later. (C). The same leg 9 months later. A permanent peroneus cast/support was acquired. The patient could not continue his
work as a driver.
710 T.A. Partanen et al.MRI. Any fluctuant, cellulitic area should be detected, and
incision and drainage performed early in order to avoid
broad-spectrum antibiotics therapy and decrease
morbidity. The patient group is prone to self-discharge, and
withdrawal from recreational drugs is time consuming. We
did not want to take a fibular graft from the healthy leg to
reconstruct the right femoral bone defect in the osteomy-
elitis patient because of her non-compliance. The risk of
bilateral femoral amputation became evident.
Injecting crushed tablets is a desperate action which
results in devastating consequences even if detected early.
Peripheral pulses are usually normal within a few hours
after IA injection e a sign that may lead the treatment
pathway to a conservative direction, even to discharging
home before a marked oedema of the affected limbs
appears. The venous system responds by venospasm, and
a venous thrombosis and a circulus vitiosus are
completed.11
This study showed that crushed-tablet abusers are at
high risk of irreversible tissue damage.
In conclusion (‘Helsinki protocol’), we would recom-
mend an intense follow-up by a vascular surgeon when an
ischaemic manifestation of crushed-tablet injection is sus-
pected. Controlled urine drug scan gives valuable infor-
mation and should be performed. Blood flow should be
monitored and angiography should be performed with a low
threshold. We recommend considering the use of iloprost.
Anticoagulation is crucial, and it is advisable to start it as
soon as possible. Rhabdomyolysis and ischaemic contrac-
tures may be prevented by fasciotomies. Abnormal paintolerance and impatience are characteristic features of
these patients. Pain medication and withdrawal therapy
should be planned carefully together with an anaesthetist
and a psychiatrist specialised in withdrawal treatment.
Physical and psychological rehabilitation should be
continued in dedicated clinics.
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